Bristol-Myers will buy Padlock in grab for autoimmune disease market

Bristol-Myers announced a purchase of the privately-held company Padlock Therapeutics Inc. on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.